N Rist
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology 22
- Epidemiology top 5%
- Mycobacterium research and diagnosis 6
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Molecular Medicine top 5%
- Surgery top 10%
- Infectious Diseases and Tuberculosis 4
- Diagnosis and treatment of tuberculosis 4
-
- Synthesis and Characterization of Heterocyclic Compounds 7
- Synthesis and Reactivity of Sulfur-Containing Compounds 6
- Synthesis and biological activity 5
- Journals
- Journal of Pharmaceutical Sciences (1 paper)Infection (1 paper)Bulletin of the World Health Organization (1 paper)
- Partner nations
- FranceSwitzerlandIran
In The Last Decade
N Rist
33 papers receiving 885 citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Infectious Diseases 891
- Epidemiology 798
- Molecular Medicine 77
- Surgery 369
- Toxicology 10
Countries citing papers authored by N Rist
This map shows the geographic impact of N Rist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Rist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Rist more than expected).
Fields of papers citing papers by N Rist
This network shows the impact of papers produced by N Rist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Rist. The network helps show where N Rist may publish in the future.
Co-authorship network
The 23 scholars most cited alongside N Rist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 3 | |
| 2 | [Controlled investigation of 3 types of oral treatment of pulmonary tuberculosis made in Morocco, at Tangiers (I.N.H. with ethioniamide; I.N.H. with PAS; I.N.H. alone). (Early results after 1 year of observation)]. | 1998 | 0 |
| 3 | [Trial chemotherapy of 103 cases of pulmonary tuberculosis, all resistant to 1 or several antibiotics, in a country with high tuberculosis endemia (early results after at least 4 months' treatment. Reflections and practical suggestions on so-called "chronic" tuberculosis)]. | 1998 | 0 |
| 4 | [Th-1314 or the thioamide of alpha-ethylisonicotinic acid in the treatment of cavitary tuberculosis]. | 1998 | 0 |
| 5 | [Bacteriological study of tuberculosis in Cameroon]. | 1971 | 15 |
| 6 | Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.breakdown → | 1969 | 643 |
| 7 | A comparative trial of two treatment regimens for pulmonary tuberculosis (ethionamide+isoniazid and thioacetazone+isoniazid). | 1968 | 0 |
| 8 | A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis. | 1968 | 13 |
| 9 | [Tuberculosis bacilli of the African type: preliminary note]. | 1968 | 44 |
| 10 | [Comparative study of 2 types of oral therapy of pulmonary tuberculosis (ethionamide and isoniazid, thiacetazone and isoniazid)]. | 1968 | 1 |
| 11 | [The BCG antibiogram. Diagnostic value of resistance to cycloserine]. | 1967 | 7 |
| 12 | [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)]. | 1964 | 8 |
| 13 | [The S-oxide of gamma-ethylthioisonicotinamide]. | 1963 | 2 |
| 14 | [Relationship between the chemical constitution and tuberculostatic activity of substituted isonicotinic thioamides]. | 1957 | 0 |
| 15 | [Experimental antituberculous activity of certain isonicotinic thioamides substituted on the nucleus]. | 1956 | 7 |
| 16 | [Preparation of new pyridinic thioamides active in experimental tuberculosis]. | 1956 | 5 |
| 17 | [Resistance of tubercle bacilli to isonicotinic hydrazide]. | 1952 | 2 |
| 18 | The Tubereulostatic Activity in the Mouse of Phenyl para-Amino-salicylate (FR7), in Oily Solution or in Aqueous Suspension, Alone or Associated with Streptomycin. | 1951 | 1 |
| 19 | [Varying aspects of the sensitivity of the tubercle bacillus to para-acetyl-benzaldehyde-thiosemicarbazone (TbI) in Youmans medium]. | 1951 | 2 |
| 20 | [A new derivative of PAS, phenyl paraaminosalicylate or FR7; tuberculostatic activity in vitro and in the mouse]. | 1951 | 2 |
About N Rist
N Rist is a scholar working on Infectious Diseases, Organic Chemistry, Epidemiology, Pharmacology and Pharmacology, having authored 42 papers that have together received 1.0k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (22 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (6 papers), Mycobacterium research and diagnosis (6 papers), Synthesis and biological activity (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Infectious Diseases and Tuberculosis (4 papers) and Diagnosis and treatment of tuberculosis (4 papers). The work is most often cited by research in Infectious Diseases (891 citations), Epidemiology (798 citations), Molecular Medicine (77 citations), Surgery (369 citations) and Toxicology (10 citations). N Rist has collaborated with scholars based in France, Switzerland and Iran. Frequent co-authors include G Canetti, H Mahler, Wallace Fox, D.A. Mitchison, N.K. Menon, A G Khomenko, J Grosset, F Grumbach, G Biozzi and A. Lind. Their work appears in journals such as Journal of Pharmaceutical Sciences, Infection, Bulletin of the World Health Organization, Tubercle and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.